Rani Therapeutics Holdings Inc (RANI) — Capital Reinvestment Ratio

Latest as of September 2020: 0.15x

Rani Therapeutics Holdings Inc (RANI) has a Capital Reinvestment Ratio of 0.15x as of September 2020, meaning it reinvests 0% of its operating cash flow ($670.00K) in capital expenditures ($99.00K). Check tangible net worth ratio of Rani Therapeutics Holdings Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.15x

Capex / Operating Cash Flow

Operating Cash Flow

$670.00K

USD

Capital Expenditures

$99.00K

USD

Data as of

Sep 2020

Most recent filing

Annual Capital Reinvestment Ratio for Rani Therapeutics Holdings Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Rani Therapeutics Holdings Inc from None to None. See Rani Therapeutics Holdings Inc (RANI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow